Picture of Luckwel Pharmaceuticals logo

LWEL Luckwel Pharmaceuticals Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro Cap

Annual cashflow statement for Luckwel Pharmaceuticals, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

2017
March 31st
2018
March 31st
2019
March 31st
2020
March 31st
2021
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.511-0.537-0.623-0.536-0.436
Amortisation
Non-Cash Items0.0060.0040
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.0440.01700.1390.238
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-0.461-0.516-0.622-0.398-0.198
Other Investing Cash Flow Items00000
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities00000
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.4040.5050.6290.3720.2
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.057-0.0110.007-0.0260.002